Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-12-14

FDA Approved: HUMATIN — Original Application (Waylis Therapeutics LLC)

View source ↗

Summary

The FDA approved Humatin (paromomycin sulfate) via an Original Application (AP) for Waylis Therapeutics LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMATIN (paromomycin sulfate)

Snippet

ORIG AP for HUMATIN (PAROMOMYCIN SULFATE)